Overview

This one-day symposium for pediatricians, family physicians and other healthcare providers will showcase the latest approach, updates and research related to several common patient issues confronted by primary care providers as well as newer and more complex diseases. Our speakers will address health concerns, share cases, and offer guidelines on how to manage the patient. We are excited to present lectures on integrative medicine, mind-body therapies, botanicals and supplements for children, integrative medicine for common GI issues, new developments in RSV injury prevention, and pediatric sleep health.

5.75 AMA PRA CATEGORY 1 CREDIT(S)TM

This course is approved for live credit only. It will not be streamed or recorded.

Due to hotel policy, there is a strict no cancellation policy that allows for cancellations up to 7 days in advance only. Consideration will be given to emergency situations and a transfer to a future event will be offered.

Thursday, November 2, 2023; 8:00 a.m. - 3:00 p.m.

Hilton Oak Brook Hills Resort & Conference Center - 3500 Midwest Road - Oak Brook, IL - 60523

Objectives

• Define Integrative Medicine and its principles and its benefits
• Discuss how Integrative Medicine may help improve provider well-being
• Identify  three different mind-body therapies for pediatric patients with GI conditions
• Describe the process of various mind-body therapies and the evidence supporting mind-body therapies
• Explain regulation of natural products and quality-related issues
• Describe common botanicals and supplements used by pediatric patients
• Review the prevalence and utilization of integrative medicine in pediatric gastroenterology
• Review rationale and evidence for use of integrative medicine in pediatric GI conditions
• Review the evidence and indications for the most common integrative medicine therapies in several specific GI conditions

• Outline the new and upcoming active vaccines for preventing severe RSV disease, including the risks and benefits for the patients who get them
• Discuss the new monoclonal antibody for preventing RSV hospitalization and illness, including which patients could benefit
• Describe the status of new antivirals with RSV activity
• Explain best practices and current evidence for safe strength training for child and adolescent patients

• Address common worries about strength training and contraindications for strength training
• Review current age-based pediatric sleep duration guidelines and evidenced-base data for these recommendations

• Recognize cultural and individual variability in sleep duration and practices
• Discuss physical, social, emotional, and cognitive outcomes of sleep disturbances
• Discuss possible interventions and uidance regarding sleep quality, timing, and duration

• Review the role of the gut microbiome in common pediatric GI conditions.
• Review the rationale and evidence for use of probiotics in pediatrics and their indications for use in several specific GI conditions.
• Participate in mind-body therapies offered during the experiential session and teach diaphragmatic breathing.
• Explain the concept of guided imagery.
• Review the current epidemiology of respiratory viruses, including the impact of the pandemic and the projections going forward
• Review current and upcoming treatment and prevention options for respiratory viruses in children

AGENDA

Credit & Accreditation Statements

Accreditation Statement: The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. American Board of Surgery Accredited CME and Self-Assessment: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to the ACCME for the purpose of granting ABS credits. Credit Designation Statement: The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

Lurie Children's CME Leadership & Staff:
Ravi Jhaveri, MD, Course Director; Claudia Cooper,CME Manager

FSM's CME Leadership & Staff:
Clara J. Schroedl, CME Medical Director; Sheryl Corey, CME Manager;  Senior Program Coordinator, Allison McCollum; Administrative Assistant, Rhea Alexis Banks have nothing to disclose.

Nothing listed if there are no disclosures

Speakers / Course Directors:

?Course Directors:

Ravi Jhaveri, MD

Receives consulting fee from AstraZeneca, Sequirus, and Dynavax and Moderna. Receives royalties and/or is a patent beneficiary of UpToDate. Is an independent contractor for Elsevier and Pediatric Infectious Diseases Society. Receives grant/research support from Glaxo Smith Kline. He is an advisor for Sanofi-Aventis.

Faculty Members and Speakers: 

Joshua Prozialeck, MD

Receives grant or research support from Ansun Biopharma, Astellas Pharm, AstraZeneca, Eli Lilly Company, Entanta Pharmaceuticals, F. Hoffmann La Roche Ltd., Gilead, Janssen Biotech, Karius Inc., Melinta Therapeutics Inc., Merc and Company Inc., Moderna, Nabriva Therapeutics, Paratek Pharmaceuticals, Inc., Pfizer, Tetraphaze Pharmaceuticals, Inc.. He is on Membership on Advisory Committees or Review Panels of Invivyd, DiaSorin Molecular LLC, Sanofi-Aventis. Receives Consulting Fee from Astra Zeneca.

Lauren Potthoff, PhD

Maria Perez, MD

Bill Muller, MD

Receives grant or research support from Ansun Biopharma, Astellas Pharm, AstraZeneca, Eli Lilly Company, Entanta Pharmaceuticals, F. Hoffmann La Roche Ltd., Gilead, Janssen Biotech, Karius Inc., Melinta Therapeutics Inc., Merc and Company Inc., Moderna, Nabriva Therapeutics, Paratek Pharmaceuticals, Inc., Pfizer, Tetraphaze Pharmaceuticals, Inc.. He is on Membership on Advisory Committees or Review Panels of Invivyd, DiaSorin Molecular LLC, Sanofi-Aventis. Receives Consulting Fee from Astra Zeneca.

Sigrid Wolf, MD

Irina Trosman, MD